Silencing of TGF-β in stromal cells co-cultured with FLT3-ITD-AML enhances treatment-induced AML apoptosis and sensitizes AML cells to combination chemotherapy [32]. The gene discussed is FLT3; the disease is acute myeloid leukemia.